Advisors Preferred »

Centessa Pharmaceuticals shares owned by Advisors Preferred

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Advisors Preferred from 13F filings

Historical chart of Advisors Preferred investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Advisors Preferred consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Advisors Preferred

Quarter filed Position value Share count Share price at filing
2024-09-30 $78k 4.6k 17.20
2024-03-31 $20k 1.8k 11.08

More positions owned by Advisors Preferred

SPDR S&P 500 ETF Trust USD Class Etf (SPY)
Vanguard Financials ETF Etf (VFH)
iShares 20 plus Year Treasury Bond ETF USD Class Etf (TLT)
iShares 1-3 Year Treasury Bond ETF USD Class Etf (SHY)
Invesco Nasdaq 100 ETF USD Class Etf (QQQM)
iShares Russell 2000 Value ETF USD Class Etf (IWN)
Schwab US Dividend Equity ETF USD Class Etf (SCHD)
Vanguard Dividend Appreciation ETF USD Class Etf (VIG)
iShares 0-3 Month Treasury Bond ETF USD Class Etf (SGOV)
Premier (PINC)
iShares 7-10 Year Treasury Bond ETF USD Class Etf (IEF)
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF Etf (XHLF)
Technology Select Sector SPDR Fund USD Class Etf (XLK)
Vanguard Long-Term Corporate Bond ETF USD Class Etf (VCLT)
WisdomTree US LargeCap Dividend Fund USD Class Etf (DLN)

View all positions for Advisors Preferred

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
EcoR1 Capital
T. Rowe Price Associates
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
TCG Crossover Management
Point72 Asset Management
Franklin Resources
Driehaus Capital Management
Avidity Partners Management
Morgan Stanley

View all funds holding Centessa Pharmaceuticals